Owner Hemoteq AG

Service Spruson & Ferguson

Various Convention priority claimed: 20 April 2001, Germany, No. 301 25 293.9 in respect of CHEMICAL SUBSTANCES, ESPECIALLY ORGANIC MACROMOLECULAR SUBSTANCES FOR THE COATING OF ARTIFICIAL AND NATURAL SURFACES; HERAPIN, HERAPIN DERIVATIVES AND ORGANIC MACROMOLECUL

Class 1 Chemical substances, including organic macromolecular substances for the coating of artificial surfaces; heparin, heparin derivatives and organic macromolecular substances with anti-thrombotic and/or anti-coagulative properties for the coating of artificial surfaces for the intra- and extracorporeal circulation and for the coating of surgical implants

Class 10 Artificial heart valves, hearts, lungs, arteries, veins, aortas; articles for medical use for contact with blood, including tubes for blood, valves, container, bags, cans, needles, catheter and artificial parts for the cardiovascular system and extracorporeal circulation; surgical implants; anti-thrombotic and/or anti- coagulative surgical implants, artificial surfaces for medical purposes, including for intra- and extracorporeal circulation; artificial surfaces and surgical implants coated with heparin, heparin derivatives or macromolecular agents, including artificial heart valves, hearts, lungs, arteries, veins, aortas; articles for medical use and for contact with blood coated with heparin, heparin derivatives or macromolecular agents, including tubes for blood, valves, container, bags, cans, needles, catheter and artificial parts for the cardiovascular system and extracorporeal circulation

Class 40 Commissioned coating work of artificial surfaces and surgical implants with biopolymers, including with heparin, heparin derivatives or anti-thrombotic and/or anti-coagulative macromolecular substances

Class 42 Commissioned research work and commissioned development work in the field of surrogates for blood and blood substitutes, blood products and blood-compatible materials and blood-compatible implants; commissioned research work, commissioned development work and advisory services in the field of the coating of artificial surfaces, surgical implants and parts for the cardiovascular system and extracorporeal circulation, including coatings with heparin, heparin derivatives or anti-thrombotic and/or anti-coagulative macromolecular substances; services of a research company in the field of biochemical, pharmaceutical and medicine-technological research work, including in the field of surrogates for blood, blood substitutes, blood products and blood-compatible materials and blood- compatible implants and blood-compatible parts for the cardiovascular system and extracorporeal circulation